Fernanda Martins Lopes

683 total citations
8 papers, 525 citations indexed

About

Fernanda Martins Lopes is a scholar working on Molecular Biology, Neurology and Organic Chemistry. According to data from OpenAlex, Fernanda Martins Lopes has authored 8 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Neurology and 2 papers in Organic Chemistry. Recurrent topics in Fernanda Martins Lopes's work include Parkinson's Disease Mechanisms and Treatments (3 papers), Autophagy in Disease and Therapy (2 papers) and Free Radicals and Antioxidants (2 papers). Fernanda Martins Lopes is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (3 papers), Autophagy in Disease and Therapy (2 papers) and Free Radicals and Antioxidants (2 papers). Fernanda Martins Lopes collaborates with scholars based in Brazil, United Kingdom and United States. Fernanda Martins Lopes's co-authors include Fábio Klamt, José Cláudio Fonseca Moreira, Carolina Müller, Marilda da Cruz Fernandes, Alfeu Zanotto‐Filho, Rosalva Thereza Meurer, Daniel Pens Gelain, Flávio Kapczinski, Rafael Schröder and André Simões Pires and has published in prestigious journals such as Cancer, Scientific Reports and Brain Research.

In The Last Decade

Fernanda Martins Lopes

8 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fernanda Martins Lopes Brazil 8 256 132 121 74 65 8 525
Hongrong Xie China 8 320 1.3× 104 0.8× 116 1.0× 65 0.9× 40 0.6× 10 554
Linsen 4 241 0.9× 125 0.9× 111 0.9× 64 0.9× 34 0.5× 9 506
Hong-rong 2 236 0.9× 124 0.9× 110 0.9× 61 0.8× 33 0.5× 2 490
Rosalva Thereza Meurer Brazil 6 199 0.8× 111 0.8× 81 0.7× 60 0.8× 39 0.6× 7 423
Linsen Hu China 12 401 1.6× 144 1.1× 128 1.1× 95 1.3× 38 0.6× 18 710
Yuen-Ting Cheung Hong Kong 9 500 2.0× 177 1.3× 99 0.8× 151 2.0× 67 1.0× 16 873
Jordi Romero‐Giménez Spain 13 238 0.9× 149 1.1× 159 1.3× 70 0.9× 84 1.3× 20 675
Carolina Perez-Pastene Chile 11 174 0.7× 126 1.0× 202 1.7× 73 1.0× 53 0.8× 11 449
Thaïs Cuadros Spain 8 216 0.8× 94 0.7× 159 1.3× 71 1.0× 66 1.0× 8 540
Mary C. Maj Canada 15 479 1.9× 122 0.9× 205 1.7× 115 1.6× 101 1.6× 29 799

Countries citing papers authored by Fernanda Martins Lopes

Since Specialization
Citations

This map shows the geographic impact of Fernanda Martins Lopes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernanda Martins Lopes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernanda Martins Lopes more than expected).

Fields of papers citing papers by Fernanda Martins Lopes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernanda Martins Lopes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernanda Martins Lopes. The network helps show where Fernanda Martins Lopes may publish in the future.

Co-authorship network of co-authors of Fernanda Martins Lopes

This figure shows the co-authorship network connecting the top 25 collaborators of Fernanda Martins Lopes. A scholar is included among the top collaborators of Fernanda Martins Lopes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernanda Martins Lopes. Fernanda Martins Lopes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Rusilowicz-Jones, Emma V., et al.. (2021). Benchmarking a highly selective USP30 inhibitor for enhancement of mitophagy and pexophagy. Life Science Alliance. 5(2). e202101287–e202101287. 37 indexed citations
2.
Lopes, Fernanda Martins, Monika A. Myszczynska, Elizabeth J. New, et al.. (2020). Oxidative switch drives mitophagy defects in dopaminergic parkin mutant patient neurons. Scientific Reports. 10(1). 15485–15485. 18 indexed citations
3.
Schmitz, Ariana Ern, Luiz Felipe de Souza, Pamela Maher, et al.. (2017). Methylglyoxal-Induced Protection Response and Toxicity: Role of Glutathione Reductase and Thioredoxin Systems. Neurotoxicity Research. 32(3). 340–350. 17 indexed citations
4.
Lopes, Fernanda Martins, Ivi Juliana Bristot, Leonardo Lisbôa da Motta, Richard B. Parsons, & Fábio Klamt. (2017). Mimicking Parkinson’s Disease in a Dish: Merits and Pitfalls of the Most Commonly used Dopaminergic In Vitro Models. NeuroMolecular Medicine. 19(2-3). 241–255. 31 indexed citations
5.
Motta, Leonardo Lisbôa da, Marco Antônio De Bastiani, Fernanda Martins Lopes, et al.. (2016). In vitro evaluation of antitumoral efficacy of catalase in combination with traditional chemotherapeutic drugs against human lung adenocarcinoma cells. Tumor Biology. 37(8). 10775–10784. 12 indexed citations
6.
Lopes, Fernanda Martins, Liana Marengo de Medeiros, Leonardo Lisbôa da Motta, et al.. (2012). Evaluation of the Neurotoxic/Neuroprotective Role of Organoselenides Using Differentiated Human Neuroblastoma SH-SY5Y Cell Line Challenged with 6-Hydroxydopamine. Neurotoxicity Research. 22(2). 138–149. 43 indexed citations
7.
Lopes, Fernanda Martins, Rafael Schröder, Alfeu Zanotto‐Filho, et al.. (2010). Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies. Brain Research. 1337. 85–94. 314 indexed citations
8.
Castro, Mauro A. A., Felipe Dal‐Pizzol, Stéphanie Zdanov, et al.. (2010). CFL1 expression levels as a prognostic and drug resistance marker in nonsmall cell lung cancer. Cancer. 116(15). 3645–3655. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026